Rallybio Corporation (RLYB)
NASDAQ: RLYBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 3:44 PM ET
RLYB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $90.34M
- P/E (TTM)
- 2.12
- EPS (TTM)
- $8.01
- Dividend yield
- None
- 52-week range
- 3.67 – 17.57
- Day range
- 16.82 – 17.01
- Volume / Avg
- 3.92K / 22.16K
- Beta
- —
- Shares outstanding
- 5.31M
- Next earnings
- Nov 5, 2026
52-week range
RLYB stock today
On Oct 8, RLYB is trading at $17.01, adding $0.075 (0.44%), versus the S&P 500's 0.49% decline. Shares are 3.2% below their 52-week high of $17.57, set on Jun 1, 2026 and 363.4% above the 52-week low of $3.67, near the top of the past year's range. RLYB is up 208.5% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 277.9%.
Rallybio trades at 2.1x its trailing twelve-month earnings per share of $8.01. Rallybio's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Rallybio
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- New Haven, CT
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
Rallybio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EQEquillium Inc. | 1.43 | +2.50% | $90.36M | vs RLYB |
| OKUROnKure Therapeutics Inc. Class A | 2.25 | -4.26% | $91.12M | vs RLYB |
| MISTMilestone Pharmaceuticals Inc. | 0.7119 | -5.98% | $88.63M | vs RLYB |
| CTORCitius Oncology Inc. | 0.8301 | -3.03% | $87.79M | vs RLYB |
| BMEABiomea Fusion Inc. | 1.36 | +3.01% | $98.33M | vs RLYB |
| PLYXPolaryx Therapeutics Inc. | 1.99 | -4.78% | $99.19M | vs RLYB |
| TELOTelomir Pharmaceuticals Inc. | 1.11 | -0.89% | $81.72M | vs RLYB |
| PMNProMIS Neurosciences Inc. | 9.03 | -0.99% | $80.98M | vs RLYB |
Indexes, lists and sector
Rallybio stock FAQ
What is Rallybio's stock price today?
RLYB last traded at $17.01 as of Oct 8, 3:44 PM EDT, up 0.44% on the day. Prices are delayed at least 15 minutes.
Does Rallybio pay a dividend?
No. Rallybio does not currently pay a regular cash dividend.
When is Rallybio's next earnings date?
Rallybio is expected to report earnings on Thursday, November 5, 2026.
What is RLYB's P/E ratio?
RLYB trades at a trailing P/E ratio of 2.12.
Has RLYB ever split its stock?
Yes. The most recent RLYB stock split was a 1-for-8 split on Feb 6, 2026.
What is the RLYB 52-week high?
The 52-week high for RLYB is $17.57 and the 52-week low is $3.67. The stock is currently 3.2% below its high.